DE, P., JA, O., HS, R., S, E., MM, S., CT, V., . . . TF, M. (2016). Oral mucosal injury caused by mammalian target of rapamycin inhibitors: Emerging perspectives on pathobiology and impact on clinical practice. Cancer medicine, 5(8), 1897. https://doi.org/10.1002/cam4.761
Chicago Style (17th ed.) CitationDE, Peterson, et al. "Oral Mucosal Injury Caused by Mammalian Target of Rapamycin Inhibitors: Emerging Perspectives on Pathobiology and Impact on Clinical Practice." Cancer Medicine 5, no. 8 (2016): 1897. https://doi.org/10.1002/cam4.761.
MLA (9th ed.) CitationDE, Peterson, et al. "Oral Mucosal Injury Caused by Mammalian Target of Rapamycin Inhibitors: Emerging Perspectives on Pathobiology and Impact on Clinical Practice." Cancer Medicine, vol. 5, no. 8, 2016, p. 1897, https://doi.org/10.1002/cam4.761.